default author photo

Christian Theilacker

Pfizer Pharma GmbH

Linkstr. 10

Berlin, Berlin 10785

Germany

  • Pfizer Pharma GmbH

SCHOLARLY PAPERS

3

DOWNLOADS

362

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

The Effect of Pneumococcal Vaccines on Nasopharyngeal Colonisation Following Human Infection Challenge with Serotype 3 and Serotype 6b

Number of pages: 27 Posted: 16 Jul 2024
Konstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, Dima El Safadi, Madlen Farrar, Andre Goncalves, Patricia Gonzalez-Dias, Stephen B. Gordon, Ashleigh Howard, Maia Lesosky, Xinxue Liu, Elena Mitsi, Christopher Myerscough, Tinashe K. Nyazika, Andrew J. Pollard, Jesús Reiné, Ryan E. Robinson, Carla Solórzano, Britta C. Urban, Yiyuan Zhang, Maria Laheurta, Christian Theilacker, Julie Catusse, Elizabeth Begier, Ye Tan, Isis Kanevsky, Luis Jodar, Bradford Gessner, Andrea M. Collins, Daniela M. Ferreira and PNEUMO 2 Study Group
Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Liverpool - School of Tropical Medicine, Imperial College London, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Wolverhampton, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Oxford, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer Pharma GmbH, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer Inc. - Medical and Scientific Affairs, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine and Independent
Downloads 170 (442,467)

Abstract:

Loading...

Infectious Diseases, Streptococcus pneumoniae, Pneumococcus, PCV13, Pneumococcal Conjugate Vaccine, PPV23, Pneumococcal polysaccharide vaccine, Serotype 3, Pneumococcal Colonisation, Immunity

2.

Impact of Serotype on Pneumococcal Conjugate Vaccine Induced Immunity

Number of pages: 40 Posted: 08 Jul 2025
Patricia Gonzalez-Dias, Andre Goncalves, Jesús Reiné, Filora Elterish, Konstantinos Liatsikos, Lauren Kerruish, Josh Hamilton, Jasmine Wright, Jamie Fowler, Ivana B. Campos, Elena Mitsi, Carla Solórzano, Elizabeth Clutterbuck, Lucy Roalfe, David Goldblatt, Andrew J. Pollard, Annaliesa S. Anderson, Maria Laheurta, Christian Theilacker, Julie Catusse, Elizabeth Begier, Ye Tan, Isis Kanevsky, Bradford D. Gessner, Britta C. Urban and Daniela M. Ferreira
Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Oxford, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Oxford, University of Oxford, Instituto Adolfo Lutz, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University College London, University College London - Great Ormond Street Institute of Child Health Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, Pfizer Worldwide Research and Development, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer Pharma GmbH, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc., Pfizer, Inc., Pfizer Inc Pennsylvania, Liverpool School of Tropical Medicine and University of Liverpool - School of Tropical Medicine
Downloads 119 (600,462)

Abstract:

Loading...

Streptococcus pneumoniae, serotype 3, serotype 6B, experimental human pneumococcal challenge model, PCV13, PPV23, humoral immunity

3.

Mathematical Modeling of Pneumococcal Transmission Dynamics in Response to PCV13 Infant Vaccination in Germany Predicts Increasing IPD Burden Due to Serotypes Included in Next-Generation PCVs

Number of pages: 24 Posted: 22 Feb 2022 Last Revised: 13 Jan 2023
Matthias Horn, Christian Theilacker, Ralf Sprenger, Christof von Eiff, Ernestine Mahar, Julia Schiffner-Rohe, Mathias W. Pletz, Mark van der Linden and Markus Scholz
University of Leipzig - Institute for Medical Informatics, Statistics and Epidemiology (IMISE), Pfizer Pharma GmbH, Pfizer Pharma GmbH, Pfizer Pharma, Pfizer Pharma GmbH, Pfizer Deutschland GmbH, Friedrich-Schiller-Universität Jena, RWTH Aachen University - RWTH University Hospital Aachen and University of Leipzig
Downloads 73 (852,604)

Abstract:

Loading...

Pneumococcal, conjugate vaccines, Pneumoccocal serotype dynamic, mathematical modelling